» Authors » Likun Ma

Likun Ma

Explore the profile of Likun Ma including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 74
Citations 570
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu H, Li Y, Fu G, An J, Chen S, Zhong Z, et al.
JACC Cardiovasc Interv . 2025 Feb; PMID: 39985511
Background: The use of drug-coated balloons is a well-established strategy for the management of coronary vessels. However, head-to-head comparisons of sirolimus-coated balloons (SCBs) and paclitaxel-coated balloons (PCBs) for treating in-stent...
2.
Liu X, Wang Q, Li X, Yang Y, Deng Y, Wang X, et al.
Circulation . 2025 Feb; PMID: 39973625
Background: Circular RNAs derived from both nuclear and mitochondrial genomes are identified in animal cells. Mitochondria-encoded circular RNAs (mecciRNAs) are attracting more attention, and several members of mecciRNAs have already...
3.
Zhang L, Ying J, Ke J, Ma L, Zhou Y
Comput Biol Chem . 2025 Jan; 115:108330. PMID: 39824141
Background And Objective: Prostate cancer (PCa) is the second most commonly diagnosed cancer in males, the mechanism of PCa with bone metastasis remains unclear. In this study, we aimed to...
4.
Shen S, Wang L, Liu Q, Wang X, Yuan Q, Zhao Y, et al.
Int Immunopharmacol . 2024 Dec; 146():113873. PMID: 39693954
After acute myocardial infarction, the heart mainly relies on fibrosis remodeling repair to maintain the structural and functional integrity of the heart, however, excessive fibrosis is an important cause of...
5.
Xu M, Wang Z, Zhang Y, Liu Y, Huang R, Han X, et al.
J Am Coll Cardiol . 2024 Oct; 84(20):2026-2036. PMID: 39387764
Background: Monoclonal antibodies against proprotein convertase subtilisin/kexin type 9 (PCSK9) have been used to reduce the level of low-density lipoprotein cholesterol (LDL-C), but require either biweekly or monthly dosing frequency....
6.
Gong K, Xue C, Feng Z, Pan R, Wang M, Chen S, et al.
Nat Commun . 2024 Sep; 15(1):7902. PMID: 39256382
No abstract available.
7.
Gao C, He X, Ouyang F, Zhang Z, Shen G, Wu M, et al.
Lancet . 2024 Sep; 404(10457):1040-1050. PMID: 39236727
Background: The long-term impact of drug-coated balloon (DCB) angioplasty for the treatment of patients with de novo coronary artery lesions remains uncertain. We aimed to assess the non-inferiority of DCB...
8.
Xue C, Zeng P, Gong K, Li Q, Feng Z, Wang M, et al.
Cell Rep . 2024 Sep; 43(9):114691. PMID: 39235944
The strategy of lowering cholesterol levels by promoting cholesterol excretion is still lacking, and few molecular targets act on multiple cholesterol metabolic processes. In this study, we find that Nogo-B...
9.
Wang X, Zhang H, Bai X, Zhang L, Li C, Mao X, et al.
Catheter Cardiovasc Interv . 2024 Sep; 104(4):664-675. PMID: 39223992
Background: Rotational atherectomy (RA) remains an integral tool for the treatment of severe coronary calcified lesions despite emergence of newer techniques. We aimed to evaluate the contemporary clinical practices and...
10.
Zhang B, Zhang Y, Zhang K, Hu K, Shi Z, Ma L
Heliyon . 2024 Aug; 10(15):e35240. PMID: 39161812
Background: Coronary microvascular dysfunction (CMD) assessed by the index of microcirculatory resistance (IMR) is associated with perioperative myocardial injury (PMI).The angiographically derived index of microcirculatory resistance (caIMR) represents a novel...